R&D News | pharmaphorum

News

ABPI launches 2021 Code of Practice

The Association of the British Pharmaceutical Industry (ABPI) has launched its 2021 Code of Practice to help companies operate to high ethical standards.

News

Real Chemistry hires new global chief inclusion and health e...

Global health innovation company Real Chemistry has announced the appointment of Mary Stutts to lead its diversity, equity and inclusion strategy.

News

Fake Dictionary, Dictionary definition of the word Schizophrenia.

Cerevel soars on first data for muscarinic schizophrenia dru...

Shares in Pfizer spinout Cerevel Therapeutics have more than doubled after it reported positive early-stage results with CVL-231, a drug for schizophrenia that it thinks could have a clear

News

Altimmune ditches nasal COVID vaccine on weak trial data

Just a few months after starting clinical trials of its nasal spray vaccine for COVID-19, US biotech Altimmune is abandoning the project, saying that it generated weaker than expected immun

News

Sanofi doubles down on mRNA jabs with €400m-a-year R&D drive

Sanofi has just significantly increased its investment in mRNA vaccine development, earmarking €400 million ($475 million) a year in R&D funding to an effort that it hopes will deliver

News

AZ, Sanofi prep filings for one-shot RSV antibody after tria...

AstraZeneca and Sanofi now have the data they need in hand to press ahead with regulatory filings next year for nirsevimab, an antibody designed to prevent respiratory syncytial virus (RSV)

ABPI launches 2021 Code of Practice

Real Chemistry hires new global chief inclusion and health e...

Cerevel soars on first data for muscarinic schizophrenia dru...

Altimmune ditches nasal COVID vaccine on weak trial data

Sanofi doubles down on mRNA jabs with €400m-a-year R&D drive

AZ, Sanofi prep filings for one-shot RSV antibody after tria...

Five indications added to Pharmacy First prescribing scheme

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks